Falsified medicines are recognised as an increasing problem in the EU and the USA where illegal online pharmacies provide the main route of distribution supplying up to 50% of all falsified medicines, according to a WHO-estimation. In the developing world, falsified medicines account for up to 30%...
Read moreEUDRAC was proud to receive the Queen’s Award for International Enterprise from the Lord-Lieutenant of Oxfordshire (The Queen’s representative in Oxfordshire) on Thursday 6th September 2018. We were joined by clients, colleagues and families to celebrate the occasion. As our award was for International Enterprise, our overseas’ clients were not able to attend in person so below are some photos of the event.
Read moreBrexit implementation period The MHRA has recently updated its information on the implications of Brexit, in particular on the terms that will be agreed for the implementation period: Market Access for Medicinal Products Manufacturing and distribution licences will continue to be recognised by the...
Read moreIt has been over a year since the EMA implemented Policy 0070 on the Publication of Clinical Trial Data; the EMA have published a guidance document and a report of the first year since it was launched (Oct 2016-Oct 2017). Under Policy 70, clinical data has now been published for over 50 products,...
Read moreCarole Pugh and Karen Goode of EUDRAC attended the recent reception hosted by Prince Charles at Buckingham Palace to celebrate the winners of the 2018 Queen’s Awards for Enterprise. The reception was held in the impressive state rooms at Buckingham Palace with the Duke of Kent also in attendance...
Read moreEUDRAC will be exhibiting at the annual DIA Annual Meeting in Boston, United States of America from 24th to 28th June 2018. Our team would be pleased to welcome you at booth number 1143 to discuss your potential regulatory affairs, pharmacovigilance and publishing needs. A member of our Management...
Read moreThis website uses cookies to ensure you get the best experience on our website. Read more.